Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
50.20
-1.50 (-2.90%)
Apr 29, 2026, 4:08 PM HKT

HKG:2315 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020
Cash & Equivalents
996.281,585403.85417.66626.62466.45
Upgrade
Short-Term Investments
---7.899.15106.98
Upgrade
Trading Asset Securities
234.82--8.498.2-
Upgrade
Cash & Short-Term Investments
1,2311,585403.85434.04643.97573.42
Upgrade
Cash Growth
152.88%292.51%-6.96%-32.60%12.30%-40.11%
Upgrade
Accounts Receivable
306.16300.31229.61142.38107.68103.09
Upgrade
Other Receivables
16.617.586.936.044.1714.96
Upgrade
Receivables
322.76317.89236.54148.43111.85118.05
Upgrade
Inventory
180.31169.87110.489.923.7321.65
Upgrade
Other Current Assets
100.1875.8765.66130.69139.74161.11
Upgrade
Total Current Assets
1,8342,149816.53723.05919.3874.24
Upgrade
Property, Plant & Equipment
1,4821,2371,2131,4511,5991,391
Upgrade
Long-Term Investments
181.98192.06222.61241.24250.819.69
Upgrade
Other Intangible Assets
50.5852.761.1428.1330.656.06
Upgrade
Long-Term Deferred Tax Assets
0.970.990.96---
Upgrade
Long-Term Deferred Charges
105.3974.9296.35---
Upgrade
Other Long-Term Assets
21.8418.365.236.16-21.86
Upgrade
Total Assets
3,6773,7242,4152,4492,8002,303
Upgrade
Accounts Payable
98.91135.83115.48175.23146.19102.44
Upgrade
Accrued Expenses
28.0599.3438.0627.8951.6253.66
Upgrade
Short-Term Debt
67153.38181.04---
Upgrade
Current Portion of Long-Term Debt
297.2836.2217.58176.84126.67-
Upgrade
Current Portion of Leases
-31.9417.8626.3644.9426.9
Upgrade
Current Income Taxes Payable
8.3624.014.514.25.02
Upgrade
Current Unearned Revenue
115.1103.76102.1969.2256.3861.58
Upgrade
Other Current Liabilities
64.39367.8358.6997.56176.06196.96
Upgrade
Total Current Liabilities
679.09930.3534.91577.62606.05446.56
Upgrade
Long-Term Debt
276.54179.88156.13173.9152.17-
Upgrade
Long-Term Leases
352.89182.67197.67167.01191.5162.9
Upgrade
Long-Term Unearned Revenue
81.8282.5484.987.0789.9392.8
Upgrade
Long-Term Deferred Tax Liabilities
---1.9--
Upgrade
Other Long-Term Liabilities
-169.52603.1651.48709.36448.55
Upgrade
Total Liabilities
1,3901,5451,5771,6591,6491,051
Upgrade
Common Stock
446.9446.9399.4399.4399.4374.93
Upgrade
Additional Paid-In Capital
3,3483,3452,2181,9921,9921,516
Upgrade
Retained Earnings
-1,469-1,573-1,754-1,787-1,404-802.32
Upgrade
Treasury Stock
-44.12-45.35-32.76-27.18-18.99-
Upgrade
Comprehensive Income & Other
0.821.332.69209.09178.32159.03
Upgrade
Total Common Equity
2,2822,175834.06785.891,1461,247
Upgrade
Minority Interest
4.544.544.554.554.554.76
Upgrade
Shareholders' Equity
2,2862,179838.6790.441,1511,252
Upgrade
Total Liabilities & Equity
3,6773,7242,4152,4492,8002,303
Upgrade
Total Debt
993.71584.09570.28544.11415.2889.8
Upgrade
Net Cash (Debt)
237.41,001-166.43-110.07228.69483.62
Upgrade
Net Cash Growth
-----52.71%-44.82%
Upgrade
Net Cash Per Share
0.592.49-0.40-0.280.601.33
Upgrade
Filing Date Shares Outstanding
452.32446.9399.4399.4399.4396.69
Upgrade
Total Common Shares Outstanding
452.32446.9399.4399.4399.4374.93
Upgrade
Working Capital
1,1551,218281.62145.43313.25427.68
Upgrade
Book Value Per Share
5.044.872.091.972.873.33
Upgrade
Tangible Book Value
2,2312,122772.92757.761,1161,241
Upgrade
Tangible Book Value Per Share
4.934.751.941.902.793.31
Upgrade
Buildings
-1,0571,057---
Upgrade
Machinery
-506.04442.161,4371,2081,107
Upgrade
Construction In Progress
-34.091.735.19268.29181.96
Upgrade
Leasehold Improvements
---240.53161.75166.43
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.